329 results match your criteria: "centre Paul Broca[Affiliation]"

Co-localization of histamine with GABA but not with galanin in the human tuberomamillary nucleus.

Brain Res

June 2002

Unité INSERM de Neurobiologie et Pharmacologie Moléculaire, Centre Paul Broca, 2ter Rue d'Alésia, 75014 Paris, France.

The presence of GABA and galanin in histaminergic neurons was previously reported in the rodent brain but whether such co-localizations also occur in the human brain was not known. We used in situ hybridization histochemistry and immunohistochemistry to study the co-localization of histamine with GABA and galanin in neurons of the tuberomamillary nucleus of adult human posterior hypothalamus. On consecutive formalin-fixed paraffin-embedded sections, co-localization was assessed using the in situ hybridization for L-histidine decarboxylase mRNA and immunocytochemistry for glutamate decarboxylase-67 kDa or galanin in the two profiles of same cell.

View Article and Find Full Text PDF

Cell-specific activity of neprilysin 2 isoforms and enzymic specificity compared with neprilysin.

Biochem J

May 2002

Unité de Neurobiologie et Pharmacologie Moléculaire (U.109) de l'INSERM, Centre Paul Broca, 2ter rue d'Alésia, 75014 Paris, France.

Neprilysin (NEP) 2 is a recently cloned glycoprotein displaying a high degree of sequence identity with neprilysin (EC 3.4.24.

View Article and Find Full Text PDF

Effects of histamine H3 receptor agonist and antagonist on histamine co-transmitter expression in rat brain.

J Neural Transm (Vienna)

March 2002

Unité INSERM U109 de Neurobiologie et Pharmacologie Moléculaire, Centre Paul Broca, Paris, France.

The histaminergic H3-receptor (H3R) controls histamine synthesis and release in the tuberomamillary nucleus. We evaluated the effects of stimulating or blocking of H(3)R on glutamate-decarboxylase 67 kDa (GAD-67) and galanin mRNA expression, two histamine co-transmitters.After in situ hybridization histochemistry (ISHH), we observed a colocalization of 100% between histidine decarboxylase (HDC) and GAD-67 or H3R and of 80 to 97% with galanin.

View Article and Find Full Text PDF
Article Synopsis
  • A patient named VSB experienced reading difficulties due to a left temporal-parietal brain lesion, but his writing abilities remained largely intact.
  • Unlike other patients with similar reading issues, VSB could not mentally visualize letters and words, showing significant impairment on visual imagery tests for orthographic material.
  • However, when allowed to trace the letters with his finger, VSB's performance improved significantly, suggesting that different cognitive codes—visual and motor—are used to access knowledge about letters and words.
View Article and Find Full Text PDF

Clinical features and assessment of severe dementia. A review.

Eur J Neurol

March 2002

INSERM U324, Centre Paul Broca, 2ter rue d'Alésia, 75014 Paris, France.

Sound understanding of the dementia syndrome requires adequate acquaintance with its entire spectrum, from the lightest to the most advanced stages. Most studies of dementia deal with light to moderate stages of the condition, while relatively little attention has been paid to its most severe stages. This review presents a clinical description of patients with severe dementia and of the tests currently available to evaluate their cognitive, behavioural, and functional status.

View Article and Find Full Text PDF

Orienting of attention in left unilateral neglect.

Neurosci Biobehav Rev

March 2002

INSERM Unit 324, Centre Paul Broca, 2ter rue d'Alésia, 75014 Paris, France.

After right posterior brain damage, patients may ignore events occurring on their left, a condition known as unilateral neglect. Although deficits at different levels of impairment may be at work in different patients, the frequency and severity of attentional problems in neglect patients have been repeatedly underlined. Recent advances in the knowledge of the mechanisms of spatial attention in normals may help characterizing these deficits.

View Article and Find Full Text PDF

The traffic light paradigm: a reaction time task to study laterally directed arm movements.

Brain Res Brain Res Protoc

February 2002

INSERM Unit 324, Centre Paul Broca, 2ter Rue d'Alesia, F-75014, Paris, France.

Patients with unilateral brain damage may show slowed or hypometric arm movements toward the contralesional space, as compared to movements directed towards the side of the brain lesion. The present article describes a reaction time paradigm devised to study accuracy and latency of directional arm movements in normal human subjects and brain-damaged patients. Experimental paradigms hitherto used to explore directional motor disorders often do not reliably disentangle between perceptual and motor factors, because they employ lateralized perceptual stimuli.

View Article and Find Full Text PDF

Histamine H3-receptor-mediated [35S]GTP gamma[S] binding: evidence for constitutive activity of the recombinant and native rat and human H3 receptors.

Br J Pharmacol

January 2002

Unité de Neurobiologie et Pharmacologie Moléculaire (U.109) de l'INSERM, Centre Paul Broca, 2ter rue d'Alésia, 75014 Paris, France.

Constitutive activity of the recombinant and native rat and human H(3) receptors (H(3)Rs) was studied using H(3)R-mediated [(35)S]GTPgamma[S] binding and [(3)H]-arachidonic acid release. Ciproxifan, an inverse agonist at the rat H(3)R (rH(3)R), decreased [(3)H]arachidonic acid release from CHO cells expressing moderate densities (approximately 200 - 300 fmol mg(-1) protein) of the human H(3)R (hH(3)R). This effect occurred with the same magnitude than at the rH(3)R.

View Article and Find Full Text PDF

Acute and chronic effects of methamphetamine on tele-methylhistamine levels in mouse brain: selective involvement of the D(2) and not D(3) receptor.

J Pharmacol Exp Ther

February 2002

Unité de Neurobiologie et Pharmacologie Moléculaire (U109) de l'Institut National de la Santé et de la Recherche Médicale, Centre Paul Broca, Paris, France.

We have explored the role of endogenous dopamine in the control of histaminergic neuron activity in mouse brain regions evaluated by changes in tele-methylhistamine (t-MeHA) levels. In vitro, methamphetamine released [(3)H]noradrenaline but failed to release [(3)H]histamine from synaptosomes. In vivo, methamphetamine enhanced t-MeHA levels by about 2-fold with ED(50) values of approximately 1 mg/kg in caudate putamen, nucleus accumbens, cerebral cortex, and hypothalamus.

View Article and Find Full Text PDF

Application of genomics to drug design: the example of the histamine H3 receptor.

Eur Neuropsychopharmacol

December 2001

Unité de Neurobiologie et Pharmacologie Moléculaire (U.109) INSERM, Centre Paul Broca, 2ter Rue d'Alésia, 75014 Paris, France.

The histamine H(3) receptor was characterized in the 1980s as an autoreceptor regulating histamine release in brain. Since then, selective drugs have been designed, many of them displaying a high potency in vivo, and used in many studies to delineate the implications of cerebral histaminergic systems in physiological functions such as arousal or cognitive functions. The recent cloning of the H(3) receptor, more than 15 years later, has allowed to start molecular studies that led to important findings for optimization of drug design.

View Article and Find Full Text PDF

Objectives: Description of 6-9 Hz rhythmic electrical activity observed on recordings from electrodes implanted in the cortex of epileptic patients undergoing presurgical evaluation.

Methods: Recordings were obtained from 74 patients with multilead electrodes in the frontal, parietal and temporal cortex. The motor task consisted of a self-paced fist clenching movement at approximately 10 s intervals.

View Article and Find Full Text PDF

Normal subjects and patients with right hemisphere lesions with or without signs of left unilateral neglect judged the length of a horizontal line presented on the left or on the right side of space. In half of the trials, the line was presented with a centrally located square or diamond, and subjects had to identify the central stimulus before performing the judgment of length. The presence of the central stimulus improved accuracy of performance in controls and in patients without neglect; neglect patients, however, produced more overestimations of left-sided lines when these was presented with a central stimulus than when the lines occurred in isolation.

View Article and Find Full Text PDF

The recent development of symptomatic pharmacological treatment for Alzheimer's disease (AD) and the probable introduction of new therapies in a near future make the assessment of dementia at its different stages an even greater scientific and public health challenge. Neuropsychological tests, together with clinical data, are at present the only in vivo non-invasive screening and diagnostic tools for AD and related disorders. This chapter reviews the application to AD of standard batteries and short screening tests.

View Article and Find Full Text PDF

Signs of unilateral neglect for events occurring in one hemispace most often result from right hemisphere lesions. Right unilateral neglect after left hemisphere damage is much rarer, and has received less attention. The present study explores the relationships between right unilateral neglect and asymmetries in producing laterally directed arm movements in the horizontal plane in left brain-damaged (LBD) patients.

View Article and Find Full Text PDF

Left unilateral neglect is a neurological condition characterized by an impairment in orienting and responding to events occurring on the left side. To gain insight into the brain mechanisms of space processing and to provide theoretical foundations for patient rehabilitation, it is important to explore the attentional bias shown by neglect patients in the light of existing models of normal attentional orienting. Three experiments tested the hypothesis that attentional bias in neglect involves primarily exogenous, or stimulus-based, orienting of attention, with relatively preserved endogenous, or voluntary, orienting.

View Article and Find Full Text PDF

Cellular biology of somatostatin receptors.

Neuropeptides

February 2001

Inserm U549, IFR Broca-Sainte Anne, Centre Paul Broca, Paris, France.

Somatostatin, and the recently discovered neuropeptide cortistatin, exert their physiological actions via a family of six G protein-coupled receptors (sst1, sst2A, sst2B, sst3, sst4, sst5). Following the cloning of somatostatin receptors significant advances have been made in our understanding of their molecular, pharmacological and signaling properties although much progress remains to be done to define their physiological role in vivo. In this review, the present knowledge regarding neuroanatomical localization, signal transduction pathways, desensitization and internalization properties of somatostatin receptors is summarized.

View Article and Find Full Text PDF

BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization.

Nature

May 2001

Unité de Neurobiologie et Pharmacologie Moléculaire, INSERM U 109, Centre Paul Broca, 2ter rue d'Alésia, 75014 Paris, France.

Brain-derived neurotrophic factor (BDNF), like other neurotrophins, is a polypeptidic factor initially regarded to be responsible for neuron proliferation, differentiation and survival, through its uptake at nerve terminals and retrograde transport to the cell body. A more diverse role for BDNF has emerged progressively from observations showing that it is also transported anterogradely, is released on neuron depolarization, and triggers rapid intracellular signals and action potentials in central neurons. Here we report that BDNF elicits long-term neuronal adaptations by controlling the responsiveness of its target neurons to the important neurotransmitter, dopamine.

View Article and Find Full Text PDF

To determine whether cellular compartmentalization of somatostatin receptors can be regulated in vivo, we examined the immunocytochemical distribution of the sst2A receptor (sst2AR) after stereotaxical injections of somatostatin analogs into the rat parietal cortex. Whereas CH-275, a sst1R agonist, failed to induce changes in the diffuse sst2AR immunostaining pattern characteristic of control animals, somatodendritic profiles displaying intracytoplasmic immunoreactive granules became apparent short-term after injection of either somatostatin or the sst2R agonist octreotide. Confocal microscopy revealed that 90% of sst2AR-immunoreactive endosome-like organelles displayed transferrin receptor immunoreactivity.

View Article and Find Full Text PDF

Chromosomal mapping and organization of the human histamine H3 receptor gene.

Neuroreport

February 2001

Unité de Neurobiologie et Pharmacologie Moléculaire (U.109), INSERM, Centre Paul Broca, Paris, France.

The histamine H3 receptor (H3R) was recently cloned, and two isoforms, termed H3L and H3S, differing in the third intracytosolic loop, were isolated but the chromosomal mapping and organization of its gene remained unknown. PCR analysis of a human x rodent cell hybrid panel indicated that the H3R gene is located in the telomeric region of chromosome 20q. Alignment of human H3R cDNA sequences with DNA sequences of this chromosome revealed that its coding region comprises three exons interrupted by two introns located in the second transmembrane domain (TM2) and second intracytosolic loop, respectively.

View Article and Find Full Text PDF

Variability of response times as a marker of diverted attention.

Neuropsychologia

April 2001

INSERM Unit 324, Centre Paul Broca, 2ter rue d'Alésia, 75014 Paris, France.

Anderson et al. (Variability not ability: another basis for performance decrements in neglect. Neuropsychologia 2000;38:785-796) have recently reported that variability of response times (RTs) progressively increases from the right to the left side in left neglect patients.

View Article and Find Full Text PDF

The rat H3 receptor: gene organization and multiple isoforms.

Biochem Biophys Res Commun

January 2001

Unité de Neurobiologie et Pharmacologie Moléculaire (U109) de l'INSERM, Centre Paul Broca, 2 ter rue d'Alésia, Paris, 75014, France.

Genomic DNA analysis revealed that the coding region of the rat histamine H3 receptor comprises three exons interrupted by two introns of approximately 1 kb each. Several H3 receptor mRNA variants were identified by PCR and cDNA cloning and sequencing. Four variants generated by pseudo-intron retention/deletion at the level of the third intracellular loop were designated H3(445), H3(413), H3(410), and H3(397), according to the length of their deduced amino acid sequence and display differential tissue expression.

View Article and Find Full Text PDF

High constitutive activity of native H3 receptors regulates histamine neurons in brain.

Nature

December 2000

Unité de Neurobiologie et Pharmacologie Moléculaire (U.109) de l'INSERM, Centre Paul Broca, Paris, France.

Some G-protein-coupled receptors display 'constitutive activity', that is, spontaneous activity in the absence of agonist. This means that a proportion of the receptor population spontaneously undergoes an allosteric transition, leading to a conformation that can bind G proteins. The process has been shown to occur with recombinant receptors expressed at high density, and/or mutated, but also non-mutated recombinant receptors expressed at physiological concentrations.

View Article and Find Full Text PDF

Distinct pharmacology of rat and human histamine H(3) receptors: role of two amino acids in the third transmembrane domain.

Br J Pharmacol

December 2000

Unité de Neurobiologie et Pharmacologie Moléculaire (U.109) de l'INSERM, Centre Paul Broca, 2ter rue d'Alésia, 75014 Paris, France.

Starting from the sequence of the human histamine H(3) receptor (hH(3)R) cDNA, we have cloned the corresponding rat cDNA. Whereas the two deduced proteins show 93.5% overall homology and differ only by five amino acid residues at the level of the transmembrane domains (TMs), some ligands displayed distinct affinities.

View Article and Find Full Text PDF

Two splice variants of the hypoxia-inducible factor HIF-1alpha as potential dimerization partners of ARNT2 in neurons.

Eur J Neurosci

October 2000

Unité de Neurobiologie et Pharmacologie Moléculaire (U.109) INSERM, Centre Paul Broca, 2ter rue d'Alésia, 75014 Paris, France.

The hypoxia-inducible factor (HIF-1alpha), a basic helix-loop-helix transcription factor, is known to heterodimerize with ARNT1, a nuclear translocator, to trigger the overexpression in many cells of genes involved in resistance to hypoxia. Although HIF-1alpha and ARNT1 are both expressed in brain, their cellular localization and function therein are unknown. Here, using in situ hybridization and immunocytochemistry, we show that HIF-1alpha is expressed in normoxic cerebral neurons together with not only ARNT1 but also ARNT2, a cerebral translocator homologous to ARNT1 but displaying, unlike ARNT1, a selective neuronal expression.

View Article and Find Full Text PDF